Cite

HARVARD Citation

    Hoang, B. et al. (2017). Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer. Cancer letters. pp. 169-179. [Online]. 
  
Back to record